Eleni Grigoriadou
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.
Journal: Frontiers in public health
Published: February 01, 2026
Neuroplasticity Across the Autism-Schizophrenia Continuum.
Journal: Biomedicines
Published: September 10, 2025
Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece.
Journal: International journal of MS care
Published: July 20, 2023
COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece.
Journal: Journal of clinical medicine
Published: June 19, 2023
A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.
Journal: Frontiers in neurology
Published: August 11, 2021
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Journal: Neurological research
Published: February 13, 2020
Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
Journal: Journal of the neurological sciences
Published: December 04, 2018
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.
Journal: Journal of the neurological sciences
Published: June 05, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026